| Venous Thromboembolic Risk Assessment of Post-Partum Females in Saudi Arabia Utilizing Royal College of Obstetrics and Gynecology Risk Assessment Model |
Ongoing |
N/A |
4 |
DIREG_L_06410 |
King Abdulaziz University Hospital (Jeddah) |
| An observational registry improving Control of Hypertension and Achieving Normalization Goal Earlier |
Ongoing |
N/A |
4 |
DIREG_L_05059 |
Erfan & Bagedo General Hospital (Jeddah) |
| The Influence of a rapid relief of gastro esophageal reflux disease (GERD) symptoms on the quality of life and patient satisfaction after initiating treatment with a Proton Pump Inhibitor. |
Ongoing |
N/A |
4 |
DRIEG_L_05705 |
University District Hospital (Jeddah) |
| International Diabetes Management Practices Study (Wave 5) |
Ongoing |
N/A |
4 |
DIREG_R_05941 |
King Fahad Hospital (Jeddah) |
| An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia |
Ongoing |
Levofloxacin |
4 |
LEVOF_L_05172 |
Erfan & Bagedo General Hospital (Jeddah) |
| A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). |
Completed |
Riociguat |
2 |
BAY 63-2521 / 13605 |
King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh) |
| Tracking Biologics Along the Silk Road |
Ongoing |
Infliximab / Golimumab / Ustekinumab |
4 |
C0168ARA40 |
King Khalid University Hospital (Riyadh) |
| The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma orOcular Hypertension. |
Ongoing |
Bimatoprost SR |
3 |
192024-092 |
King Khaled Eye Specialist Hospital (Riyadh), King Abdullah Medical City (Makkah) |
| Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT) |
Ongoing |
Aspirin |
3 |
ICR-02/ASCOLT |
King Fahad Medical City (Riyadh) |
| Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI) |
Ongoing |
NILOTINIB |
4 |
RC12/052/R |
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
